ELAN News and Press, Elanco Animal Health Incorporated From 02/21/23

Elanco Animal Health ( NYSE: ELAN ) Q4 top and bottom line beat estimates but the company's FY23 adjusted EPS outlook is seen below estimates. Q4 adjusted EPS declined -9.5% Y/Y to $0.19, while total revenue fell -11.2% Y/Y to $988M. However, both figures surpassed analysts expec...

Elanco press release ( NYSE: ELAN ): Q4 Non-GAAP EPS of $0.19 beats by $0.06 . Revenue of $988M (-11.0% Y/Y) beats by $7.06M . Adjusted EBITDA of $174 million or 17.6% of Revenue Full Year 2023 Guidance: Revenue of $4,280 to $4,400 million vs. consensus...

Fourth Quarter 2022 Financial Results: Revenue of $988 million Reported Net Loss of $54 million, Adjusted Net Income of $95 million Adjusted EBITDA of $174 million or 17.6% of Revenue Reported EPS of $(0.11), Adjusted EPS of $0.19 Net le...

Tim Bettington joins Elanco as EVP Corporate Strategy and Market Development Elanco Animal Health (NYSE: ELAN) announced today the appointment of Tim Bettington as the company’s executive vice president Corporate Strategy and Market Development. He will join Elanco’s execu...

Elanco ( NYSE: ELAN ) is scheduled to announce Q4 earnings results on Tuesday, February 21st, before market open. The consensus EPS Estimate is $0.13 (-38.1% Y/Y) and the consensus Revenue Estimate is $980.94M (-11.6% Y/Y). Over the last 2 years, ELAN has beaten EPS estimate...

Elanco Animal Health Incorporated (NYSE: ELAN) will announce its fourth quarter and full year 2022 financial results on Tuesday, February 21, 2023. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company’s performance. ...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes trading in ...

The following slide deck was published by Elanco Animal Health Incorporated in conjunction with this event. For further details see: Elanco Animal Health (ELAN) presents at 41st Annual J.P. Morgan Healthcare Conference - Slideshow

Summary Jeff Smith’s 13F portfolio value decreased from $5.50B to $4.55B this quarter. Starboard Value added Wix.com while decreasing ON Semiconductor and Huntsman Corp. The largest three individual stock positions are GoDaddy, Aecom, and Humana. They add up to ~34% of the po...

Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the 41 st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023. Jeff Simmons, president and CEO, will represent the company and respond to questions from analysts at 12:45 p.m. ET. A live audio webcast wil...